Benzylpenicillin, acetylcysteine and silibinin as antidotes in human hepatocytes intoxicated with α-amanitin

Experimental and Toxicologic Pathology

Volumn 62, Issue 4, 2010, Pages 367-373

  Magdalan, Jan ^a   Ostrowska, Alina ^a   Piotrowska, Aleksandra ^a   Gomułkiewicz, Agnieszka ^a   Podhorska Okołów, Marzena ^a   Patrzałek, Dariusz ^a   Szelag, Adam ^a   Dziegiel, Piotr ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Acetylcysteine; Alpha amanitin; Amanita phalloides; Benzylpenicillin; Human hepatocytes; Intoxication; Silibinin

Indexed keywords

ACETYLCYSTEINE; ALPHA AMANITIN; LACTATE DEHYDROGENASE; PENICILLIN G; SILIBININ;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CELL SPREADING; CELL VIABILITY; COMPARATIVE STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME ACTIVITY; EXPOSURE; HUMAN; HUMAN CELL; LIVER CELL; LIVER TOXICITY;

ACETYLCYSTEINE; ALPHA-AMANITIN; ANTIDOTES; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; HUMANS; PENICILLIN G; POISONS; SILYMARIN;

AMANITA PHALLOIDES; BASIDIOMYCOTA;

EID: 77953614363     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.05.003     Document Type: Article

References (31)

1. Anker A. Acetaminophen. Clinical Toxicology 2001, 265-274. Saunders Company, Philadelphia, London, New York, St. Louis, Sydney, Toronto. M.D. Ford, K.A. Delaney, L.J. Ling, W.B. Erickson (Eds.).
2. De LaPuerta R., Martinez E., Bravo L., Ahumada C. Effects of silymarin on different acute inflammation models and on leukocyte migration. J Pharm Pharmacol 1996, 48:968-970.
3. Enjalbert A., Rapior S., Nouguier-Soule J., Guillon S., Amoroux N., Cabot C. Treatment of amatoxin poisoning: 20-Year retrospective analysis. J Toxicol Clin Toxicol 2002, 40:715-757.
4. Erguven M., Yilmaz O., Deveci M., Aksu N., Dursun F., Pelit M., et al. Mushroom poisoning. Indian J Pediatr 2007, 74:847-852.
5. Escudié L., Francoz C., Vinel J.P., Moucari R., Cournot M., Paradis V., et al. Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol 2007, 46:466-473.
6. Fraschini F., Demartini G., Esposti D. Pharmacology of silymarin. Clin Drug Invest 2002, 22:51-65.
7. Ganzert M., Felgenhauer N., Schuster T., Eyer F., Gourdin C., Zilker T. Amanita poisoning - comparison of silibinin with a combination of silibinin and penicillin. Dtsch Med Wochenschr 2008, 133:2261-2267.
8. Giannini L., Vannacci A., Missanelli A., Mastroianni R., Mannaioni P.F., Moroni F., et al. Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patients. Clin Toxicol 2007, 45:539-542.
9. Heilmeyer W., Plempel M., Otten H. Antibiotika-Fibel. Antibiotika und Chemotherapie. 3 Auflage 1969, Georg Thieme Verlag, Stuttgart.
10. Jaeger A., Jehl F., Flesch F., Sauder P., Kopferschmitt J. Kinetics of amatoxins in human poisoning: therapeutic implications. J Toxicol Clin Toxicol 1993, 31:63-80.
11. Kawaji A., Sone T., Natsuki R., Isobe M., Takabatake E., Yamaura Y. In vitro toxicity test of poisonous mushroom extracts with isolated rat hepatocytes. J Toxicol Sci 1990, 12:141-142.
12. Kim Y.C., Kim E.J., Lee E.D., Kim J.H., Jang S.W., Kim Y.G., et al. Comparative bioavailability of silibinin in healthy male volunteers. Int J Clin Pharmacol Ther 2003, 41:593-596.
13. Kotwica M., Czerczak S. Acute poisonings registered since 1970: trends and characteristics. Analysis of the files collected in the National Poison Centre, Lódz, Poland. Int J Occup Med Environ Health 2007, 20:38-43.
14. Krenova M., Pelclova D., Navratil T. Survey of Amanita phalloides poisoning: clinical findings and follow-up evaluation. Hum Exp Toxicol 2007, 26:955-961.
15. Letschert K., Faulstich H., Keller D., Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci 2006, 91:140-149.
16. Leuterburg B.H., Corcoran G.B., Mitchell J.R. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983, 71:980-991.
17. Lorenz D., Lucker P.W., Mennicke W.H., Wetzelsberger N. Pharmacokinetic studies with silymarin in human serum and bile. Methods Find Exp Clin Pharmacol 1984, 6:655-661.
18. Magdalan J., Chlebda E., Kwiatkowska J. Rat liver catalase protection from α-amanitin in extracorporeal liver perfusion. Adv Clin Exp Med 2008, 17:269-273.
19. Magdalan J., Ostrowska A., Piotrowska A., Izykowska I., Nowak M., Szelag A., et al. Failure of benzylpenicillin, N-acetylcysteine and silibinin to reduce α-amanitin hepatotoxicity. In Vivo 2009, 23:393-400.
20. Nguyen V.T., Giannoni F., Dubois M.F., Seo S.J., Vigneron M., Kedinger C., et al. In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res 1996, 24:2924-2929.
21. Ostrowska A., Bode D.C., Pruss J., Bilir B., Smith G.D., Zeisloft S. Investigation of functional and morphological integrity of freshly isolated and cryopreserved human hepatocytes. Cell Tissue Bank 2000, 1:55-68.
22. Prescott L.F., Donovan J.W., Jarvie D.R., Proudfoot A.T. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989, 37:501-506.
23. Rudd M., Luse D. Amanitin greatly reduces the rate of transcription by RNA polymerase II ternary complexes but fails to inhibit some transcript cleavage modes. J Biol Chem 1996, 271:21549-21558.
24. Saller R., Brignoli R., Melzer J., Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed 2008, 15:9-20.
25. Schneider S.M. Mushrooms. Clinical Toxicology 2001, 899-909. Saunders Company, Philadelphia, London, New York, St. Louis, Sydney, Toronto. M.D. Ford, K.A. Delaney, L.J. Ling, W.B. Erickson (Eds.).
26. Schneider S.M., Michelson E.A., Vanscoy G.J. Failure of N-acetylcysteine to reduce alpha-amanitin toxicity. J Appl Toxicol 1992, 12:141-142.
27. Tong T.C., Hernandez M., Richardson W.H., Betten D.P., Favata M., Riffenburgh R.H., et al. Comparative treatment of alpha-amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin in a murine model. Ann Emerg Med 2007, 50:282-288.
28. Vogel G., Tuchweber B., Trost W., Mengs U. Protection of silibinin against Amanita phalloides intoxication in beagles. Toxicol Appl Pharmacol 1984, 73:355-362.
29. Wellington K., Jarvis B. Silymarin. A review of its clinical properties in the management of hepatic disorders. BioDrugs 2001, 15:465-489.
30. Yildiz B.D., Abbasoglu O., Saglam A., Sökmensüer C. Urgent liver transplantation for Amanita phalloides poisoning. Pediatr Transplant 2008, 12:105-108.
31. Zheleva A., Tolekova A., Zhelev M., Uzunova V., Platikanova M., Gadzheva V. Free radical formation might contribute to the severe amatoxin hepatotoxicity - a hypotesis. Med Hypotheses 2007, 69:361-367.